Fig. 2From: Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patientsSurvival analysis of elderly breast cancer patients according to IL-5 or IL-17 production by Her-2-stimulated CD4+ T-cells. a Patients grouped according to IL-5 production; b IL-17 productionBack to article page